Plunkett Research Online: CytRx Corporation

CYTRX CORPORATION (CYTR:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

CytRx Corporation is a biopharmaceutical company specializing in the research and development of oncology treatment therapeutics. The firm is currently focused on the clinical development of aldoxorubicin, its modified version of the widely-used chemotherapeutic agent doxorubicin. CytRx has report.....



CytRx Corporation
Ticker: CYTR
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 310-826-5648
Fax: 310-826-6139
Address: 11726 San Vicente Boulevard
Suite 650
Los Angeles, CA 90049 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Research & Development
Small-Molecule Drugs
ContactsDescription
Steven KriegsmanCEO/Director/Chairman of the Board
John CalozCFO/Chief Accounting Officer
See More
CytRx Corporation is a biopharmaceutical company specializing in the research and development of oncology treatment therapeutics. The firm is currently focused on the clinical development of aldoxorubicin, its modified version of the widely-used chemotherapeutic agent doxorubicin. CytRx has report.....See More See More

Auditor: BDO USA, LLP
Legal Advisor: TroyGould PC
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
aldoxorubicin
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors:

Employee benefits include medical, dental, prescription and vision coverage; a 401(k); life and AD&D insurance; short- and long-term disability; flexible spending accounts; tuition reimbursement; and an incentive stock option plan.